137 related articles for article (PubMed ID: 38428450)
1. An association between plasma levels of α2-macroglobulin and α1-antitrypsin in PiMM and PiZZ individuals differing in COPD presentation.
Lechowicz U; Martinez-Delgado B; Liu B; Wrenger S; Rozy A; Zdral A; DeLuca DS; Welte T; Janciauskiene S; Chorostowska-Wynimko J
Clin Biochem; 2024 Apr; 126():110736. PubMed ID: 38428450
[TBL] [Abstract][Full Text] [Related]
2. Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years.
Piitulainen E; Mostafavi B; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2017; 12():495-500. PubMed ID: 28203073
[TBL] [Abstract][Full Text] [Related]
3. Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in alfa-1 anti-trypsin deficiency-related COPD development?
Pini L; Tiberio L; Arici M; Corda L; Giordani J; Bargagli E; Tantucci C
Monaldi Arch Chest Dis; 2021 Jun; 91(4):. PubMed ID: 34468105
[TBL] [Abstract][Full Text] [Related]
4. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.
Green CE; Vayalapra S; Hampson JA; Mukherjee D; Stockley RA; Turner AM
Thorax; 2015 Oct; 70(10):939-45. PubMed ID: 26141072
[TBL] [Abstract][Full Text] [Related]
5. Blood monocyte profiles in COPD patients with PiMM and PiZZ α1-antitrypsin.
Stolk J; Aggarwal N; Hochnadel I; Wrenger S; Martinez-Delgado B; Welte T; Yevsa T; Janciauskiene S
Respir Med; 2019 Mar; 148():60-62. PubMed ID: 30827477
[TBL] [Abstract][Full Text] [Related]
6. Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.
Molloy K; Hersh CP; Morris VB; Carroll TP; O'Connor CA; Lasky-Su JA; Greene CM; O'Neill SJ; Silverman EK; McElvaney NG
Am J Respir Crit Care Med; 2014 Feb; 189(4):419-27. PubMed ID: 24428606
[TBL] [Abstract][Full Text] [Related]
7. α
Bazzan E; Tinè M; Biondini D; Benetti R; Baraldo S; Turato G; Fagiuoli S; Sonzogni A; Rigobello C; Rea F; Calabrese F; Foschino-Barbaro MP; Miranda E; Lomas DA; Saetta M; Cosio MG
Chest; 2018 Sep; 154(3):607-616. PubMed ID: 29763589
[TBL] [Abstract][Full Text] [Related]
8. Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?
Carleo A; Chorostowska-Wynimko J; Koeck T; Mischak H; Czajkowska-Malinowska M; Rozy A; Welte T; Janciauskiene S
Int J Chron Obstruct Pulmon Dis; 2017; 12():829-837. PubMed ID: 28331304
[TBL] [Abstract][Full Text] [Related]
9. Lung function and CT lung densitometry in 37- to 39-year-old individuals with alpha-1-antitrypsin deficiency.
Mostafavi B; Diaz S; Piitulainen E; Stoel BC; Wollmer P; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2018; 13():3689-3698. PubMed ID: 30510411
[TBL] [Abstract][Full Text] [Related]
10. Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patients.
Turner AM; Stolk J; Bals R; Lickliter JD; Hamilton J; Christianson DR; Given BD; Burdon JG; Loomba R; Stoller JK; Teckman JH
J Hepatol; 2018 Aug; 69(2):378-384. PubMed ID: 29572094
[TBL] [Abstract][Full Text] [Related]
11. Different Training-Induced Skeletal Muscle Adaptations in COPD Patients with and without Alpha-1 Antitrypsin Deficiency.
Jarosch I; Gehlert S; Jacko D; Koczulla RA; Wencker M; Welte T; Bloch W; Janciauskiene S; Kenn K
Respiration; 2016; 92(5):339-347. PubMed ID: 27686000
[TBL] [Abstract][Full Text] [Related]
12. The effects of weekly augmentation therapy in patients with PiZZ α1-antitrypsin deficiency.
Schmid ST; Koepke J; Dresel M; Hattesohl A; Frenzel E; Perez J; Lomas DA; Miranda E; Greulich T; Noeske S; Wencker M; Teschler H; Vogelmeier C; Janciauskiene S; Koczulla AR
Int J Chron Obstruct Pulmon Dis; 2012; 7():687-96. PubMed ID: 23055718
[TBL] [Abstract][Full Text] [Related]
13. New Findings in PiZZ alpha1-antitrypsin deficiency-related panniculitis. Demonstration of skin polymers and high dosing requirements of intravenous augmentation therapy.
Gross B; Grebe M; Wencker M; Stoller JK; Bjursten LM; Janciauskiene S
Dermatology; 2009; 218(4):370-5. PubMed ID: 19218787
[TBL] [Abstract][Full Text] [Related]
14. The Swedish α1-Antitrypsin Screening Study: Health Status and Lung and Liver Function at Age 34.
Tanash HA; Nystedt-Düzakin M; Montero LC; Sveger T; Piitulainen E
Ann Am Thorac Soc; 2015 Jun; 12(6):807-12. PubMed ID: 25803183
[TBL] [Abstract][Full Text] [Related]
15. Relation of functional characteristics and serum alpha-1-antitrypsin (AAT) concentration in patients with PiMM phenotype and chronic obstructive pulmonary disease (COPD).
Zarić B; Stojčević J; Andrijević L; Andrijević I; Kuruc V; Veselinović I; Salatić I
Eur J Intern Med; 2011 Dec; 22(6):603-6. PubMed ID: 22075288
[TBL] [Abstract][Full Text] [Related]
16. Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease.
Serban KA; Pratte KA; Strange C; Sandhaus RA; Turner AM; Beiko T; Spittle DA; Maier L; Hamzeh N; Silverman EK; Hobbs BD; Hersh CP; DeMeo DL; Cho MH; Bowler RP
EBioMedicine; 2022 Oct; 84():104262. PubMed ID: 36155958
[TBL] [Abstract][Full Text] [Related]
17. Liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age.
Mostafavi B; Diaz S; Tanash HA; Piitulainen E
Medicine (Baltimore); 2017 Mar; 96(12):e6180. PubMed ID: 28328804
[TBL] [Abstract][Full Text] [Related]
18. Endotoxin receptor CD14 in PiZ alpha-1-antitrypsin deficiency individuals.
Sandström CS; Novoradovskaya N; Cilio CM; Piitulainen E; Sveger T; Janciauskiene S
Respir Res; 2008 Apr; 9(1):34. PubMed ID: 18426570
[TBL] [Abstract][Full Text] [Related]
19. Lung Function and Health Status in Individuals with Severe Alpha-1-Antitrypsin Deficiency at the Age of 42.
Schramm GR; Mostafavi B; Piitulainen E; Wollmer P; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2021; 16():3477-3485. PubMed ID: 34992356
[TBL] [Abstract][Full Text] [Related]
20. Exhaled nitric oxide in patients with PiZZ phenotype-related alpha1-anti-trypsin deficiency.
Malerba M; Clini E; Cremona G; Radaeli A; Bianchi L; Corda L; Pini L; Ricciardolo F; Grassi V; Ambrosino N
Respir Med; 2001 Jun; 95(6):520-5. PubMed ID: 11421511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
